Vandenabeele P, Melino G
Hypoglycemia when combined with other medications: While Ozempic alone does not typically cause hypoglycemia (low blood sugar), the risk increases when used in combination with other diabetes medications like insulin or sulfonylureas
Orforglipron can be manufactured through standard chemical synthesis without the complex peptide production processes required for semaglutide and tirzepatide
Because it suppresses appetite and improves blood sugar control, it has been discussed for off-label weight loss use however, this is actively discouraged by NICE and the MHRA to protect supply for diabetes patients
TRPV1 modulation is crucial in diabetic neuropathic pain, involving ROS and cytokine pathways [119,120]
Marso SP, Daniels GH, Brown-Frandsen K, LEADER Steering Committee, LEADER Trial Investigators, et al